<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">Treatment development for COVID-19 has focused on repurposing existing drugs targeting the virus directly or mitigating the excessive inflammatory response it triggers. Convalescent plasma therapy (CPT) and drugs that were used for similar diseases including SARS, Middle East respiratory syndrome (MERS), and Ebola have emerged as treatment options because of their known safety profiles and availability. The current evidence for the most promising COVID-19 emerging therapies identified in a LitCovid literature hub search of 5788 total publications is reviewed below and summarized in 
 <xref rid="tbl1" ref-type="table">TableÂ 1</xref> .
</p>
